According to Precedence Research, the global homeopathic products market size is forecasted to reach US$ 19.7 billion by 2030 from US$ 6.9 billion in 2021, by growing at a lucrative CAGR of 12.3% between 2021 and 2030.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.
The increasing demand for the complementary and alternative medicine is expected to drive the global homeopathic product market. According to the British Homeopathic Association, homeopathy is a natural form of medicine that cures both the acute and chronic diseases from the roots and prevents ant type of side-effects. As per the data published by the Homeopathy Research Institute, around 200 million people across the globe use homeopathic products on a regular basis.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1350
The rising prevalence of chronic diseases among the population is a significant driver of the homeopathic product market. According to the World Health Organization, the developing countries are expected to witness maximum number of chronic diseases among its population owing to the rapidly growing population. Furthermore, the rising inclination towards the non-invasive treatment is fostering the market growth. The invasive treatment are too costly and certain health complications may arise after the treatment. On the other hand, the homeopathy offers orally administered medicines and are free from side effects and are cheaper. This is a major driver of the homeopathic product market.
The rising investments in the expansion, new product launches, and research & developmental activities adopted by the top players are expected to boost the growth of the market during the forecast period. Companies are trying to develop innovative ways to extract ingredients from plants and minerals. Furthermore, the surging awareness among the population regarding the gene-targeted treatment in the homeopathy is resulting in a burgeoning demand for the homeopathic products across the globe.
The rising prevalence of chronic diseases, growing geriatric population, high healthcare expenses related to the modern healthcare treatment centers, rising awareness regarding the effectiveness of homeopathy medicines, cheaper cost of medicines, and rising consumer expenditure on health and wellness are some of the important factors that are accountable for the growth of the global homeopathic product market during the forecast period.
Report Highlights
- Based on product type, the market is segmented into dilutions, tincture, tablets, bio-chemics, ointments and others. The dilutions segment accounted largest revenue share in 2020 and the trend is likely to continue during the forecast period. The tablets segment is projected to witness fastest growing segment in near future.
- Based on application, the market is segmented into analgesic and antipyretic, dermatology, respiratory, neurology, immunology, gastroenterology, and others. The analgesic and antipyretic segment accounted largest revenue share in 2020. On the other hand, the respiratory segment is anticipated to grow at a remarkable CAGR over the forecast period 2021 to 2030.
- Based on source, the plant segment dominated market share for over 65% in 2020, owing to the extensive use of plants, herbs, vegetable, flowers, roots, leaves, and fruits in the preparation of medicines across the globe.
- Based on region, Europe dominated the market with 65% revenue share in 2020 due to growing geriatric population.
Competitive Intelligence
The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.
Some of the prominent players in the global homeopathic products market are listed as below:
- BoironUSA
- BiologischeHeilmittel Heel GmbH
- A Nelson & Co Ltd
- Homeocaninc.
- SBL
- Hahnemann Laboratories
- Mediral International Inc
- AinsworthsLtd.
- Hevert – Arzneimittel GmbH & Co. KG
- BioIndiaPharma
- Bioforce
- SchwabeGroup
- Lord’S Homeopathic Laboratory (P) Ltd.
- Hyland’s Homeopathic
- Arogya
- Bakson
- Helios Homeopathy
- Rxhomeo
Segments Covered in the Report
By Product
- Dilutions
- Tincture
- Tablets
- Others
By Application
- Analgesic and Antipyretic
- Respiratory
- Neurology
- Others
By Source
- Plants
- Animals
- Minerals
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global homeopathic products market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for homeopathic products are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Homeopathic Products Market
5.1. COVID-19 Landscape: Homeopathic Products Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Homeopathic Products Market, By Product
8.1. Homeopathic Products Market, by Product Type, 2021-2030
8.1.1. Dilutions
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Tincture
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Tablets
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Homeopathic Products Market, By Application
9.1. Homeopathic Products Market, by Application, 2021-2030
9.1.1. Analgesic and Antipyretic
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Respiratory
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Neurology
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Homeopathic Products Market, By Source
10.1. Homeopathic Products Market, by Source, 2021-2030
10.1.1. Plants
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Animals
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Minerals
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Homeopathic Products Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by Source (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by Source (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Source (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by Source (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by Source (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Source (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Source (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Source (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by Source (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by Source (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Source (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Source (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Source (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by Source (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by Source (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Source (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Source (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Source (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by Source (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by Source (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Source (2019-2030)
Chapter 12. Company Profiles
12.1. BoironUSA
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BiologischeHeilmittel Heel GmbH
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. A Nelson & Co Ltd
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Homeocaninc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. SBL
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Hahnemann Laboratories
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Mediral International Inc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. AinsworthsLtd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Hevert – Arzneimittel GmbH & Co. KG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. BioIndiaPharma
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Bioforce
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. SchwabeGroup
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Lord’S Homeopathic Laboratory (P) Ltd.
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1350
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com